{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T15:08:35Z","timestamp":1774364915657,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Journal"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.bj.2020.12.002","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T05:49:23Z","timestamp":1607579363000},"page":"74-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Phytochemicals against SARS-CoV as potential drug leads"],"prefix":"10.1016","volume":"44","author":[{"given":"Shasank Sekhar","family":"Swain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3123-1218","authenticated-orcid":false,"given":"Sujogya Kumar","family":"Panda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Luyten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bj.2020.12.002_bib1","author":"WHO"},{"key":"10.1016\/j.bj.2020.12.002_bib2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","article-title":"A novel coronavirus outbreak of global health concern","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bj.2020.12.002_bib3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12931-020-01479-w","article-title":"From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses","volume":"21","author":"Zhu","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.bj.2020.12.002_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bj.2020.12.002_bib5","first-page":"1824","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review","volume":"323","author":"Sanders","year":"2020","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.bj.2020.12.002_bib6","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3389\/fmicb.2020.01800","article-title":"Geographic and genomic distribution of SARS-CoV-2 mutations","volume":"11","author":"Mercatelli","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bj.2020.12.002_bib7","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1186\/s12889-020-09826-8","article-title":"COVID-19 mortality risk for older men and women","volume":"20","author":"Yanez","year":"2020","journal-title":"BMC Publ Health"},{"key":"10.1016\/j.bj.2020.12.002_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003321","article-title":"Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: a federated electronic medical record analysis","volume":"17","author":"Harrison","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.bj.2020.12.002_bib9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s13054-020-03120-0","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19","volume":"24","author":"Ni","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.bj.2020.12.002_bib10","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.3390\/molecules25173920","article-title":"Design and evaluation of anti-SARS-coronavirus agents based on molecular interactions with the viral protease","volume":"25","author":"Akaji","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bj.2020.12.002_bib11","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/v4061011","article-title":"Mechanisms of coronavirus cell entry mediated by the viral spike protein","volume":"4","author":"Belouzard","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.bj.2020.12.002_bib12","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3389\/fphar.2020.01258","article-title":"Repurposing drugs, ongoing vaccine, and new therapeutic development initiatives against COVID-19","volume":"11","author":"Saha","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bj.2020.12.002_bib13","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1016\/j.bmc.2013.03.027","article-title":"Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa","volume":"21","author":"Cho","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bj.2020.12.002_bib14","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3390\/biom9110696","article-title":"Natural Bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus oc43 infection of MRC-5 human lung cells","volume":"9","author":"Kim","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.bj.2020.12.002_bib15","doi-asserted-by":"crossref","first-page":"15199","DOI":"10.1128\/JVI.79.24.15199-15208.2005","article-title":"The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme","volume":"79","author":"Lindner","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.bj.2020.12.002_bib16","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1073\/pnas.0510851103","article-title":"Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme","volume":"103","author":"Ratia","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bj.2020.12.002_bib17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bj.2020.12.002_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/14756366.2019.1690480","article-title":"Inhibition of SARS-CoV 3CL protease by flavonoids","volume":"35","author":"Jo","year":"2020","journal-title":"J Enzym Inhib Med Chem"},{"key":"10.1016\/j.bj.2020.12.002_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s43141-020-00085-z","article-title":"A comprehensive review on promising anti-viral therapeutic candidates identified against main protease from SARS-CoV-2 through various computational methods","volume":"18","author":"Singh","year":"2020","journal-title":"J Genet Eng Biotechnol"},{"key":"10.1016\/j.bj.2020.12.002_bib20","first-page":"1","article-title":"Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CLpro)","author":"Koulgi","year":"2020","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bj.2020.12.002_bib21","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3389\/fmed.2020.00444","article-title":"Plants Metabolites: possibility of natural therapeutics against the COVID-19 pandemic","volume":"7","author":"Bhuiyan","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.bj.2020.12.002_bib22","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/plants9060800","article-title":"Aromatic herbs, medicinal plant-derived essential oils, and phytochemical extracts as potential therapies for Coronaviruses: future perspectives","volume":"9","author":"Boukhatem","year":"2020","journal-title":"Plants"},{"key":"10.1016\/j.bj.2020.12.002_bib24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/molecules21050559","article-title":"The traditional medicine and modern medicine from natural products","volume":"21","author":"Yuan","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.bj.2020.12.002_bib26","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1021\/jm070295s","article-title":"Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus","volume":"50","author":"Wen","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.bj.2020.12.002_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.antiviral.2005.07.002","article-title":"Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds","volume":"68","author":"Lin","year":"2005","journal-title":"Antivir Res"},{"key":"10.1016\/j.bj.2020.12.002_bib28","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1016\/j.bmc.2010.09.035","article-title":"Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL (pro) inhibition","volume":"18","author":"Ryu","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bj.2020.12.002_bib29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/14756366.2012.753591","article-title":"Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia","volume":"29","author":"Kim","year":"2014","journal-title":"J Enzym Inhib Med Chem"},{"key":"10.1016\/j.bj.2020.12.002_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00023-19","article-title":"High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses","volume":"93","author":"Shen","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.bj.2020.12.002_bib31","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/14756366.2016.1265519","article-title":"Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors","volume":"32","author":"Park","year":"2017","journal-title":"J Enzym Inhib Med Chem"},{"key":"10.1016\/j.bj.2020.12.002_bib32","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.2147\/IJN.S31379","article-title":"A facile inhibitor screening of SARS coronavirus N-protein using nanoparticle-based RNA oligonucleotide","volume":"7","author":"Roh","year":"2012","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.bj.2020.12.002_bib33","first-page":"493","article-title":"Antiviral activity of cepharanthine against severe acute respiratory syndrome coronavirus in\u00a0vitro","volume":"118","author":"Zhang","year":"2005","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.bj.2020.12.002_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.antiviral.2009.02.001","article-title":"Procyanidins and butanol extract of Cinnamomi cortex inhibit SARS-CoV infection","volume":"82","author":"Zhuang","year":"2009","journal-title":"Antivir Res"},{"key":"10.1016\/j.bj.2020.12.002_bib35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.antiviral.2006.04.014","article-title":"Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction","volume":"74","author":"Ho","year":"2007","journal-title":"Antivir Res"},{"key":"10.1016\/j.bj.2020.12.002_bib36","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1021\/jm0493008","article-title":"Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus","volume":"48","author":"Hoever","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bj.2020.12.002_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2014.11.010","article-title":"A screen of the NIH clinical collection small molecule library identifies potential anti-coronavirus drugs","volume":"114","author":"Cao","year":"2015","journal-title":"Antivir Res"},{"key":"10.1016\/j.bj.2020.12.002_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-0033-1360277","article-title":"Kaempferol derivatives as antiviral drugs against the 3a channel protein of coronavirus","volume":"80","author":"Schwarz","year":"2014","journal-title":"Planta Med"},{"key":"10.1016\/j.bj.2020.12.002_bib39","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1016\/j.bmcl.2012.04.081","article-title":"Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13","volume":"22","author":"Yu","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bj.2020.12.002_bib40","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1016\/j.bmc.2012.07.038","article-title":"Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases","volume":"20","author":"Park","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bj.2020.12.002_bib41","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1440-1681.2006.04415.x","article-title":"Antiviral effects of saikosaponins on human coronavirus 229E in\u00a0vitro","volume":"33","author":"Cheng","year":"2006","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.bj.2020.12.002_bib42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.antiviral.2017.12.010","article-title":"Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses","volume":"150","author":"M\u00fcller","year":"2018","journal-title":"Antivir Res"},{"key":"10.1016\/j.bj.2020.12.002_bib43","doi-asserted-by":"crossref","first-page":"11334","DOI":"10.1128\/JVI.78.20.11334-11339.2004","article-title":"Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells","volume":"78","author":"Yi","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.bj.2020.12.002_bib44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/ecam\/neh081","article-title":"Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3'-digallate (TF3)","volume":"2","author":"Chen","year":"2005","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.bj.2020.12.002_bib45","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.antiviral.2010.08.009","article-title":"Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirus","volume":"88","author":"Yang","year":"2010","journal-title":"Antivir Res"},{"key":"10.1016\/j.bj.2020.12.002_bib46","first-page":"1415","article-title":"Anti-human coronavirus (anti-HCoV) triterpenoids from the leaves of Euphorbia neriifolia","volume":"7","author":"Chang","year":"2012","journal-title":"Nat Prod Commun"},{"key":"10.1016\/j.bj.2020.12.002_bib47","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1038\/s41598-020-63913-9","article-title":"Computer-aided synthesis of dapsone-phytochemical conjugates against dapsone-resistant Mycobacterium leprae","volume":"10","author":"Swain","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.bj.2020.12.002_bib48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13020-020-00317-x","article-title":"Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan, Hubei Province, China","volume":"15","author":"Luo","year":"2020","journal-title":"Chin Med"},{"key":"10.1016\/j.bj.2020.12.002_bib49","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.ajem.2020.03.046","article-title":"Is traditional Chinese medicine useful in the treatment of COVID-19?","volume":"38","author":"Zhang","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.bj.2020.12.002_bib50","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"Andersen","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.bj.2020.12.002_bib51","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/d41587-020-00003-1","article-title":"Coronavirus puts drug repurposing on the fast track","volume":"38","author":"Harrison","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.bj.2020.12.002_bib52","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.joim.2020.02.005","article-title":"In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus","volume":"18","author":"Zhang","year":"2020","journal-title":"J Integr Med"},{"key":"10.1016\/j.bj.2020.12.002_bib53","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.bj.2020.08.003","article-title":"Machine learning techniques for sequence-based prediction of viral-host interactions between SARS-CoV-2 and human proteins","volume":"43","author":"Dey","year":"2020","journal-title":"Biomed J"}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417020302298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417020302298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:07:47Z","timestamp":1762420067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2319417020302298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2319417020302298"],"URL":"https:\/\/doi.org\/10.1016\/j.bj.2020.12.002","relation":{},"ISSN":["2319-4170"],"issn-type":[{"value":"2319-4170","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phytochemicals against SARS-CoV as potential drug leads","name":"articletitle","label":"Article Title"},{"value":"Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bj.2020.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Chang Gung University. Publishing services provided by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}